Rectal neuroendocrine tumors (NETs) are the most common gastrointestinal (GI) NETs with
an uncertain malignant potential despite their small size. There are limited data about driver …

Serotonin producing pancreatic neuroendocrine tumors (SP-PanNET) account for 0.58–
1.4% of all pancreatic neuroendocrine tumors (PanNET). They may present with atypical …

Gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) with favorable
pathological and clinical features may be considered as indolent lesions, and therefore be …

Pancreatic ductal adenocarcinoma (PDAC) is a dreaded malignancy with a dismal 5-year
survival rate despite maximal efforts on optimizing treatment strategies. Radical surgery is …

Neuroendocrine neoplasms (NENs) are initially monoclonal neoplasms that progressively
become polyclonal, with very different genotypic and phenotypic characteristics leading to …

Pancreatic neuroendocrine neoplasms (panNENs) are the second most common epithelial
tumors of the pancreas. Despite improvements in prognostic grading and staging systems, it …

Abstract Background Pancreatic neuroendocrine tumors (PanNETs) exhibit heterogenous
behavior, whereby some small tumors are aggressive with a propensity for metastasis …

Objective: The objective of this study was to describe the pattern of recurrence, treatments
received, as well the oncological outcomes, of pancreatic neuroendocrine tumors …

Telomeres are nucleoprotein complexes located at the termini of eukaryotic chromosomes
that prevent exonucleolytic degradation and end-to-end chromosomal fusions. Cancers …

Opinion statement Pancreatic neuroendocrine neoplasms (PanNENs) are increasingly
recognized entities, whose incidence has dramatically grown during the last two decades …